West Pharmaceutical Services retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $3.857B, a 12.91% increase year-over-year.
West Pharmaceutical Services retained earnings (accumulated deficit) for 2023 were $3.523B, a 17.93% increase from 2022.
West Pharmaceutical Services retained earnings (accumulated deficit) for 2022 were $2.988B, a 21.62% increase from 2021.
West Pharmaceutical Services retained earnings (accumulated deficit) for 2021 were $2.457B, a 33.03% increase from 2020.
West Pharmaceutical Services Retained Earnings (Accumulated Deficit) 2010-2024 | WST